Medical science has made some huge strides in the last decade or so attempting to understand and defeat cancer. Scientists can now make certain cancerous cells kill each other among other treatments but there is still no definitive cure for the deadly disease.
But now, Sean Parker, the founder of Napster and co-founder of Facebook, has put his considerable weight behind a project that is determined to defeat cancer once and for all.
According to the Washington Post, Parker is backing a $250 million effort to create a super team of scientists that will dedicate their time and efforts on killing cancer.
Advert
Apparently 300 scientists are already working on the project in world-class laboratories across America despite the plan only being announced earlier this week.
Parker said: "Cancer immunotherapy is such an incredibly complex field, and for every answer it seems to pose 10 more questions. I'm an entrepreneur so I wish some of these questions had been answered yesterday."
The project intends to concentrate on immunotherapy which is more about encouraging our own immune system's to fight cancer rather than chemotherapy physically destroying cancerous tissue.
Parker claims the team of scientists working together with the money donated will be the perfect way of removing any bureaucracy as they don't have to apply for funding - it's already there.
Advert
The scientists may be spending most of their time at their own institutions but all information gathered will be collated at the non-profit Parker Institute for Cancer Immunotherapy in San Francisco, and every person involved in the project will have access to that data.
Only time will tell whether this massive collaboration will prove to be the end of cancer, but it's better than sitting around doing nothing.
Now let's all sit back and watch the 'they've found a cure but they don't want to release it because it's a huge profitable industry' people come out of the woodwork.
Props to Sean Parker.
Advert
Words by George Pavlou
Images credited to Getty
Featured Image Credit:Topics: Cancer